FPF
PLXP

FNY Partners Fund’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

FNY Partners Fund’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-63
Closed -$5K – 1259
2017
Q1 		$5K Buy
+63
New +$685 ﹤0.01% 1195

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
HWA
Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FNY Partners Fund's PLXP Position: Q2 2017 in Review

FNY Partners Fund sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2017, closing a stake of 63 shares — an estimated $5K sold.

FNY Partners Fund first reported a position in PLXP in Q1 2017 and held it in 1 quarter. The position peaked at $5K in Q1 2017. 14 funds tracked by Wall St. Rank hold PLXP as of Q2 2017.

  • FNY Partners Fund reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • FNY Partners Fund sold 63 PLx Pharma Inc. Common Stock shares in Q2 2017, an estimated $5K.
  • FNY Partners Fund first reported a position in PLx Pharma Inc. Common Stock in Q1 2017 and held it in 1 quarter.
  • FNY Partners Fund's PLx Pharma Inc. Common Stock position peaked at $5K in Q1 2017.
  • 14 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.